ArticleThe Journal of antimicrobial chemotherapy2023

High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated β-lactamase CMY-185 variant.

William C Shropshire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.